Concepedia

Stephen D’Amico

SD

Statistics

Publications

11

Citations

460

H-Index

10

Active since

1992

Affiliations

Stony Brook University(Current)

Meridien Research

Avanir Pharmaceuticals (United States)

Baylor College of Medicine

Stephen D’Amico is an author at Stony Brook University specializing in medicine, oncology, and neurologic pharmacotherapy.

Publications per year

1992–2024

11

Publications

11

KRAS drives immune evasion in a genetic model of pancreatic cancer

Irene Ischenko, Stephen D’Amico, Manisha Rao et al. · Nature Communications · 2021 · 188 citations · Full text

Medicine, Cancer Biology, Oncology +17

STAT3 is a master regulator of epithelial identity and KRAS-driven tumorigenesis

Stephen D’Amico, Jiaqi Shi, Benjamin L. Martin et al. · Genes & Development · 2018 · 72 citations · Full text

Medicine, Molecular Biology, Oncology +13

[Mixed depressive syndrome].

Alexia E. Koukopoulos, Gianni L. Faedda, Riccardo Proietti et al. · PubMed · 1992 · 48 citations

Medicine, Pharmacology, Psychiatry +17

PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury

Flora M. Hammond, David N. Alexander, Andrew J. Cutler et al. · BMC Neurology · 2016 · 36 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +17

Quantification of external urethral sphincter and bladder activity during micturition in the intact and spinally transected adult rat

Stephen D’Amico, Isaiah P. Schuster, William F. Collins · Experimental Neurology · 2010 · 32 citations

Medicine, Physiology, Urology +13

1–5 of 11